The alzheimer’s disease-related glucose metabolic brain pattern

Current Alzheimer Research

Volumn 11, Issue 8, 2014, Pages 725-732

  Teune, Laura K ^a   Strijkert, Fijanne ^a   Renken, Remco J ^a   Izaks, Gerbrand J ^a   De Vries, Jeroen J ^a   Segbers, Marcel ^a   Roerdink, Jos B T M ^b   Dierckx, Rudi A J O ^a   Leenders, Klaus L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Alzheimer s disease; Clinical diagnosis; Disease specific metabolic brain patterns; FDG PET imaging; Neuropsychological profiles; SSM PCA method

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

AGED; ALZHEIMER DISEASE; ANGULAR GYRUS; AREA UNDER THE CURVE; ARTICLE; CALCARINE SULCUS; CEREBELLUM; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; GLUCOSE METABOLIC BRAIN PATTERN; GLUCOSE METABOLISM; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NONBIOLOGICAL MODEL; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; POSTCENTRAL GYRUS; POSTERIOR CINGULATE; PRECUNEUS; PREDICTIVE VALUE; PRIMARY MOTOR CORTEX; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCALED SUBPROFILE MODEL; SENSITIVITY AND SPECIFICITY; SENSORIMOTOR CORTEX; SUBCORTEX; SUPRAMARGINAL GYRUS; TEMPORAL LOBE; WHITE MATTER; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; COMPLICATION; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; SCINTISCANNING;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84926195127     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720501108140910114230     Document Type: Article

References (42)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34: 939-44 (1984)
2. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. Lancet 367: 1262-70 (2006)
3. Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: A review of the recent literature. J Nucl Med 53: 59-71 (2012)
4. Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 25: 2395-404 (2010)
5. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42(1): 85-94 (1997)
6. Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with lewy bodies: Cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50: 358-65 (2001)
7. Silverman DH, Small GW, Chang CY, Lu CS, Aburto KD, Chen W, et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 286(17): 2120-7 (2001)
8. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD Eur J Nucl Med Mol Imaging 32(4): 486-510 (2005)
9. Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130: 2616-35 (2007)
10. Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 12(4): 851-5 (2001)
11. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolicht L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17: 302-16 (2002)
12. Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60(8): 1374-7 (2003)
13. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30(8):1104-13 (2003)
14. Chen K, Ayutyanont N, Langbaum JBS, Fleischer AS, Reschke C, Lee W, et al. Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage 56: 52-60 (2011)
15. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, et al. Associations between cognitive, functional and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32: 1207-1218 (2011)
16. Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, et al. Summary metrics to assess Alzheimer Disease-related hypometabolic pattern with 18F-FDG PET: Head to head comparison. J Nucl Med 53: 592-600 (2012)
17. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends Neurosci 32: 548-57 (2009)
18. Habeck C, Foster NL, Perneczky R, Kurz A, Alexopoulos P, Koeppe RA, et al. Multivariate and univariate neuroimaging biomarkers of alzheimer's disease. Neuroimage 40: 1503-15 (2008)
19. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in parkinson's disease: Test-retest reproducibility. J Cereb Blood Flow Metab 27: 597-605 (2007)
20. Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 23(5): 727-33 (2008)
21. Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, et al. Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis. Lancet Neurol 9: 149-58 (2010)
22. Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel J, et al. Network correlates of disease severity in multiple system atrophy. Neurology 78: 1237-44 (2012)
23. Teune LK, Renken RJ, Mudali D, de Jong BM, Dierckx RA, Roerdink JBTM, et al. Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord 28(4): 547-51 (2013)
24. Huang C, Eidelberg D, Habeck C, Moeller J, Svensson L, Tarabula T, et al. Imaging markers of mild cognitive impairment: Multivariate analysis of CBF SPECT. Neurobiol Aging 28: 1062-9 (2007)
25. Alexander G.E, Prohovnik I, Stern Y, Mayeux R. WAIS-R subtest profile and cortical perfusion in Alzheimer's Disease. Brain and Cognition 24: 24-43 (1994)
26. Scarmeas N, Habeck CG, Zarahn E, Anderson KE, Park A, Hilton J, et al. Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: Utility in group discrimination and correlations with functional performance. Neuroimage 23: 35-45 (2004)
27. Asllani I, Habeck C, Scarmeas N, Borogovac A, Brown TR, Stern Y. Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J Cereb Blood Flow Metab 28: 725-36 (2008)
28. Petersen RC. Mild cognitive impairment: current research and clinical implications. Semin Neurol 27(1): 22-31 (2007)
29. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2): 250-60 (1993)
30. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12): 1863- 72 (2005)
31. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58(11): 1803-9 (2001)
32. Folstein M, Folstein S, McHugh P. "Mini[1]mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12: 189-98 (1975)
33. Saan RJ, Deelman BG. The 15 words test (a temporary manual). department of neuropsychology, University Medical Center Groningen, Groningen, the Netherlands 1986
34. Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C. Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 73: 126-33 (2002)
35. Stroop J. Studies of interference in serial verbal reactions. J Exp Psychology 18: 643-662 (1935)
36. Reitan R. Validity of the trail making test as an indicator of organic brain damage. Perceptual and motor skills 8: 271-276 (1958)
37. Warrington EK, James M. The visual object and space perception battery: Test Manual. Thames Valley Test Company 1991; Bury St Edmunds, England
38. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside. Neurology 55: 1621-6 (2000)
39. Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ. Behavioural assessment of the dysexecutive syndrome: Test Manual. Thames Valley Test Company 1996; Bury St Edmunds, England
40. Spetsieris PG, Eidelberg D. Scaled subprofile modeling of resting state imaging data in parkinson's disease: Methodological issues. Neuroimage 54(4): 2899-914 (2011)
41. Akaike H. A new look at the statistical model identification. IEEE Trans automatic contr 19(6): 716-23 (1974)
42. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, et al. The 18F.fluorodeoxy-glucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44: 127-37 (1979).